| Product Code: ETC7923874 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to rely heavily on vaccine contract manufacturing imports from top exporters such as Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a steep decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remained robust at 43.42%. The high Herfindahl-Hirschman Index (HHI) indicates significant market concentration, highlighting the dominant position of these key exporting countries in supplying vaccines to Latvia. This data underscores the importance of monitoring market dynamics and fostering diversified supply chains for vaccine manufacturing in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Vaccine Contract Manufacturing Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Vaccine Contract Manufacturing Market - Industry Life Cycle |
3.4 Latvia Vaccine Contract Manufacturing Market - Porter's Five Forces |
3.5 Latvia Vaccine Contract Manufacturing Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Latvia Vaccine Contract Manufacturing Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Latvia Vaccine Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines globally, driving the need for contract manufacturing services |
4.2.2 Growing focus on outsourcing to specialized contract manufacturers for cost-efficiency and expertise |
4.2.3 Technological advancements in vaccine manufacturing processes leading to increased outsourcing opportunities |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent quality control requirements in vaccine production |
4.3.2 Limited capacity and capabilities of local contract manufacturers in Latvia |
5 Latvia Vaccine Contract Manufacturing Market Trends |
6 Latvia Vaccine Contract Manufacturing Market, By Types |
6.1 Latvia Vaccine Contract Manufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Fill-Finish, 2022 - 2032F |
6.1.4 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Bulk Product, 2022 - 2032F |
6.2 Latvia Vaccine Contract Manufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.2.3 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Biotech Companies, 2022 - 2032F |
6.2.4 Latvia Vaccine Contract Manufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
7 Latvia Vaccine Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Latvia Vaccine Contract Manufacturing Market Export to Major Countries |
7.2 Latvia Vaccine Contract Manufacturing Market Imports from Major Countries |
8 Latvia Vaccine Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in the number of vaccine development projects outsourced to contract manufacturers in Latvia |
8.2 Average turnaround time for vaccine manufacturing contracts in Latvia |
8.3 Number of new partnerships formed between Latvian contract manufacturers and global pharmaceutical companies for vaccine production |
9 Latvia Vaccine Contract Manufacturing Market - Opportunity Assessment |
9.1 Latvia Vaccine Contract Manufacturing Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Latvia Vaccine Contract Manufacturing Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Latvia Vaccine Contract Manufacturing Market - Competitive Landscape |
10.1 Latvia Vaccine Contract Manufacturing Market Revenue Share, By Companies, 2025 |
10.2 Latvia Vaccine Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here